Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios
Cancers · 25.08.2024 · 16 (17) · 2965
DOI: 10.3390/cancers16172965 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.08.2024. Verfasst von Laura Samà und 13 weiteren Autor:innen. Beteiligte Einrichtung: Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesenchymal tumors originate from mesenchymal cells and can be either benign or malignant, such as bone, soft tissue, and visceral sarcomas. Surgery is a cornerstone treatment in the management of mesenchymal tumors, often requiring complex procedures performed in high-volume referral centers. However, the COVID-19 pandemic has highlighted this need for alternative non-surgical approaches due to limited access to surgical resources. This review explores the role of non-surgical treatments in different clinical scenarios: for improving surgical outcomes, as a bridge to surgery, as better alternatives to surgery, and for non-curative treatment when surgery is not feasible. We discuss the effectiveness of active surveillance, cryoablation, high-intensity focused ultrasound, and other ablative techniques in managing these tumors. Additionally, we examine the use of tyrosine kinase inhibitors in gastrointestinal stromal tumors and hypofractionated radiotherapy in soft tissue sarcomas. The Sarculator tool is highlighted for its role in stratifying high-risk sarcoma patients and personalizing treatment plans. While surgery remains the mainstay of treatment, integrating advanced non-surgical strategies can enhance therapeutic possibilities and patient care, especially in specific clinical settings with limitations. A multidisciplinary approach in referral centers is vital to determine the optimal treatment course for each patient.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
- Department of Pathology, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
- Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
- Radiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
ORCID-Profile: Laura Samà, Laura Ruspi, Federico Sicoli, Elena Clerici, Pierina Navarria, Marta Scorsetti
Zitieren
APA
Samà, L., Rodda, G. A., Ruspi, L., Sicoli, F., D'Amato, V., Renne, S. L., Laffi, A., Baldaccini, D., Clerici, E., Navarria, P., Scorsetti, M., Bertuzzi, A. F., Quagliuolo, V. L., & Cananzi, F. C. M. (2024). Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios. Cancers, 16(17), 2965. https://doi.org/10.3390/cancers16172965
Vancouver
Samà L, Rodda GA, Ruspi L, Sicoli F, D'Amato V, Renne SL, et al. Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios. Cancers. 2024;16(17):2965. doi:10.3390/cancers16172965
BibTeX
@article{Sam2024,
author = {Samà, Laura and Rodda, Giorgia Amy and Ruspi, Laura and Sicoli, Federico and D'Amato, Vittoria and Renne, Salvatore Lorenzo and Laffi, Alice and Baldaccini, Davide and Clerici, Elena and Navarria, Pierina and Scorsetti, Marta and Bertuzzi, Alexia Francesca and Quagliuolo, Vittorio Lorenzo and Cananzi, Ferdinando Carlo Maria},
title = {Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios},
journal = {Cancers},
year = {2024},
volume = {16},
number = {17},
pages = {2965},
doi = {10.3390/cancers16172965}
}
EUVIMED